SMTL ID : 1sbg.1

AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLACEMENT. CRYSTALLOGRAPHIC AND PHARMACOKINETIC ANALYSIS

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-dimer

Ligands

1 x IM1: (2R,4S,5S,1'S)-2-PHENYLMETHYL-4-HYDROXY-5-(TERT-BUTOXYCARBONYL)AMINO-6-PHENYL HEXANOYL-N-(1'-IMIDAZO-2-YL)-2'-METHYLPROPANAMIDE(Non-covalent)

IM1.1: 26 residues within 4Å: Chain A: R.8, L.23, D.25, G.27, A.28, D.29, D.30, V.32, I.47, G.49, I.50, P.81, V.82, I.84 Chain B: L.23, D.25, G.27, A.28, D.29, D.30, G.48, G.49, I.50, P.81, V.82, I.84 20 PLIP interactions: 9 interactions with chain A, 11 interactions with chain B Hydrophobic interactions: A:L.23, A:V.32, A:I.47, A:P.81, A:V.82, A:V.82, B:L.23, B:A.28, B:D.30, B:I.50, B:P.81, B:V.82, B:I.84 Hydrogen bonds: A:G.27, B:D.25, B:G.27, B:G.27, B:D.29 Water bridges: A:I.50, A:I.50

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Abdel-Meguid, S.S. et al., An orally bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement: crystallographic and pharmacokinetic analysis. Biochemistry (1994)

Release Date

1994-10-15

Peptides

HIV-1 PROTEASE: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

HIV-1 PROTEASE

Related Entries With Identical Sequence